Next Article in Journal
Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria?
Next Article in Special Issue
The Role of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infections: A Review of the Current Literature and Paradigm Shift after 2021
Previous Article in Journal
Investigation of In Vitro Susceptibility and Resistance Mechanisms in Skin Pathogens: Perspectives for Fluoroquinolone Therapy in Canine Pyoderma
Previous Article in Special Issue
The Risk of Clostridioides difficile Recurrence after Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health Facts
 
 
Article

Article Versions Notes

Antibiotics 2022, 11(9), 1203; https://doi.org/10.3390/antibiotics11091203
Action Date Notes Link
article xml file uploaded 6 September 2022 13:24 CEST Original file -
article xml uploaded. 6 September 2022 13:24 CEST Update https://www.mdpi.com/2079-6382/11/9/1203/xml
article pdf uploaded. 6 September 2022 13:24 CEST Version of Record https://www.mdpi.com/2079-6382/11/9/1203/pdf
article supplementary file uploaded. 6 September 2022 13:24 CEST - https://www.mdpi.com/2079-6382/11/9/1203#supplementary
article html file updated 6 September 2022 13:25 CEST Original file -
article html file updated 28 February 2023 12:30 CET Update https://www.mdpi.com/2079-6382/11/9/1203/html
Back to TopTop